I now have comprehensive content across all major physiological topics. Let me compile the full detailed answer.
Clinical Physiology of the Respiratory System
Overview
Respiratory physiology encompasses the mechanics of breathing, gas exchange, lung volumes, ventilation-perfusion relationships, oxygen transport, control of breathing, and the response to pathological states. Each topic has direct clinical implications.
1. Mechanics of Breathing
Inspiration (Active Process)
Muscular contraction causes the diaphragm to descend and ribs to pivot outward, expanding the thoracic cavity. This generates negative intrapleural pressure (drops from -5 to -8 or -9 cm H₂O during inspiration), which lowers alveolar pressure below atmospheric, establishing a gradient that drives airflow inward.
Transpulmonary pressure (P_TP):
P_TP = P_alveolar - P_intrapleural
At end-expiration: P_TP = 0 - (-5) = +5 cm H₂O
Expiration (Passive at Rest)
Elastic recoil of the previously expanded lung parenchyma drives gas out. No muscular work is required during quiet breathing. Active expiration recruits abdominal muscles and internal intercostals.
Clinical point: Normal spontaneous breathing spends more time in exhalation (Te) than inspiration (Ti) because a compliant lung fills quickly. An I:E ratio of 1:2 is the normal baseline.
Minute Ventilation (V̇E)
V̇E = Respiratory Rate × Tidal Volume
Normal = 6-8 L/min at rest.
2. Elastic Properties - Compliance & Surface Tension
Compliance
Compliance (C) = ΔVolume / ΔPressure - the ease of lung distension.
| Component | Normal Value | Notes |
|---|
| Lung compliance (CL) | 150-200 mL/cm H₂O | Reduced by fibrosis, edema, ARDS |
| Chest wall compliance (CW) | 200 mL/cm H₂O | Reduced by obesity, ascites, supine position |
| Total compliance (lung + chest wall) | ~100 mL/cm H₂O | 1/C_total = 1/CL + 1/CW |
Clinical point: A stiff lung (low compliance) requires greater effort or pressure to achieve the same tidal volume. In ARDS, lung compliance drops dramatically - ventilating these patients with low tidal volumes (6 mL/kg IBW) protects against barotrauma.
Surface Tension & Surfactant
The air-fluid interface in alveoli behaves like a bubble, obeying Laplace's Law:
Pressure = 2 × Surface tension / Radius
Without surfactant, smaller alveoli (higher pressure due to smaller radius) would empty into larger ones - causing alveolar collapse. Surfactant (produced by type II pneumocytes) reduces surface tension in proportion to its concentration:
- As alveoli shrink → surfactant becomes more concentrated → surface tension falls → prevents further collapse
- As alveoli enlarge → surfactant becomes more dilute → surface tension rises → prevents overdistension
This mechanism stabilizes alveolar size and prevents atelectasis.
Clinical point: Surfactant deficiency in premature neonates causes Neonatal Respiratory Distress Syndrome (NRDS). In ARDS, damaged type II cells cannot maintain surfactant, worsening alveolar collapse.
3. Lung Volumes & Capacities
| Parameter | Abbreviation | Normal (Adult) | Definition |
|---|
| Tidal Volume | VT | ~500 mL | Volume per normal breath |
| Inspiratory Reserve Volume | IRV | ~3000 mL | Extra volume above VT |
| Expiratory Reserve Volume | ERV | ~1200 mL | Extra volume exhaled beyond VT |
| Residual Volume | RV | ~1200 mL | Volume remaining after maximal exhalation (cannot be measured by spirometry) |
| Inspiratory Capacity | IC | VT + IRV | Max inspired from FRC |
| Functional Residual Capacity | FRC | ERV + RV (~2400 mL) | Volume at end-expiration at rest |
| Vital Capacity | VC | IRV + VT + ERV (~4600 mL) | Max volume from full expiration to full inspiration |
| Total Lung Capacity | TLC | ~6000 mL | All four volumes combined |
| Forced Expiratory Volume (1 sec) | FEV₁ | >80% of FVC | Key spirometric parameter |
| FEV₁/FVC ratio | - | >0.7 (>70%) | <70% = obstructive defect |
Clinical point: FRC is the lung volume at rest where elastic inward recoil of the lung balances elastic outward recoil of the chest wall. FRC falls in supine position, obesity, pregnancy, and with general anesthesia (by ~15-20%). A reduced FRC below closing capacity (CC) causes small airway closure during tidal breathing, leading to intrapulmonary shunting and hypoxemia.
Obstructive vs. Restrictive Patterns
| Feature | Obstructive (e.g., COPD, Asthma) | Restrictive (e.g., fibrosis, obesity) |
|---|
| FVC | Normal or ↓ | ↓↓ |
| FEV₁ | ↓↓ | ↓ |
| FEV₁/FVC | <0.7 | Normal or ↑ |
| TLC | ↑ (air trapping) | ↓ |
| RV | ↑ | ↓ |
4. Airway Resistance
Normal total airway resistance: 0.5-2 cm H₂O/L/s
The largest contribution comes from medium-sized bronchi (generation 4-7) - not from large or small airways.
Flow Types
- Laminar flow: Concentric cylinders; governed by Hagen-Poiseuille law (resistance ∝ 1/r⁴); occurs in small airways (<1 mm)
- Turbulent flow: Random movement; resistance ∝ gas density / r⁵; occurs in large airways at high flow rates
Reynolds number predicts flow type:
Re = (velocity × diameter × density) / viscosity
- Re < 1000 → laminar
- Re > 1500 → turbulent
Clinical point: Helium has a lower density-to-viscosity ratio than oxygen. A Heliox (He-O₂) mixture reduces turbulent flow and airway resistance in upper airway obstruction (e.g., croup, subglottic stenosis) - a useful temporizing bridge.
Factors Increasing Airway Resistance
- Bronchospasm (asthma)
- Mucosal edema (anaphylaxis, infection)
- Secretions
- Low lung volume (loss of radial traction on small airways) - corrected by PEEP
5. Ventilation-Perfusion (V̇/Q̇) Relationships
The cornerstone of clinical respiratory physiology.
Normal V̇/Q̇ = 0.8
(Total alveolar ventilation ~4 L/min; total perfusion ~5 L/min)
Gravity-Dependent Zonal Differences (West's Zones)
In the upright lung:
| Zone | Location | V̇/Q̇ | PaO₂ | PaCO₂ | Mechanism |
|---|
| Zone 1 (apex) | Upper | 3.0 (highest) | 130 mmHg | 28 mmHg | Minimal perfusion; relative over-ventilation |
| Zone 2 (mid) | Middle | ~1.0 | - | - | Balanced ventilation and perfusion |
| Zone 3 (base) | Lower | 0.6 (lowest) | 89 mmHg | 42 mmHg | Highest perfusion; relative under-ventilation |
Clinical relevance: Tuberculosis preferentially affects the lung apex (Zone 1 - high V̇/Q̇, high O₂ tension) because M. tuberculosis is an obligate aerobe that thrives in oxygen-rich environments.
V̇/Q̇ Extremes - Spectrum of Defects
| V̇/Q̇ | Condition | Cause | Gas exchange effect |
|---|
| V̇/Q̇ = ∞ | Dead space | No perfusion (PE, shock) | PAO₂ = 150 mmHg; PACO₂ = 0; wasted ventilation |
| V̇/Q̇ high | High V̇/Q̇ | Reduced perfusion | High PO₂, low PCO₂ in capillary blood |
| V̇/Q̇ = 0.8 | Normal | Matched V/Q | Normal gas exchange |
| V̇/Q̇ low | Low V̇/Q̇ | Reduced ventilation (mucus plugging, partial obstruction) | Low PO₂, high PCO₂ in capillary blood |
| V̇/Q̇ = 0 | Shunt | No ventilation (consolidation, atelectasis, R→L cardiac shunt) | PaO₂ = 40 mmHg; PaCO₂ = 46 mmHg (same as mixed venous) |
Key Clinical Distinction: Dead Space vs. Shunt
- Dead space (high V̇/Q̇): hypercapnia dominates; CO₂ rises because it cannot be eliminated. Example: pulmonary embolism
- Shunt (V̇/Q̇ = 0): hypoxemia that is refractory to supplemental O₂ (blood bypasses alveoli entirely). Example: lobar pneumonia, ARDS, ASD with Eisenmenger
Key point: Low V̇/Q̇ (not absolute shunt) can be at least partially corrected by increasing FiO₂. True shunt cannot - this is the clinical basis for the 100% O₂ test.
Venous Admixture (Physiologic Shunt Equation)
$$\frac{\dot{Q}_S}{\dot{Q}_T} = \frac{Cc'O_2 - CaO_2}{Cc'O_2 - C\bar{v}O_2}$$
Where Cc'O₂ = ideal pulmonary end-capillary O₂ content; CaO₂ = arterial O₂ content; CvO₂ = mixed venous O₂ content
Normal shunt fraction = <5%
6. Gas Exchange & the Alveolar Gas Equation
Alveolar Gas Equation
$$P_AO_2 = F_iO_2 \times (P_{atm} - P_{H_2O}) - \frac{P_aCO_2}{R}$$
Where R = respiratory quotient (~0.8); PH₂O = 47 mmHg at 37°C
At sea level breathing room air (FiO₂ = 0.21):
PAO₂ = 0.21 × (760 - 47) - 40/0.8 = ~100 mmHg
Alveolar-Arterial (A-a) Gradient
A-a gradient = PAO₂ - PaO₂
- Normal A-a gradient: 5-15 mmHg in young adults (increases with age and FiO₂)
- Estimated normal: ~(Age/4) + 4 mmHg
Elevated A-a gradient causes of hypoxemia:
- V̇/Q̇ mismatch
- Right-to-left shunt
- Diffusion impairment (rare at rest; occurs with exercise or thickened membrane)
Normal A-a gradient causes of hypoxemia:
- Hypoventilation (PaCO₂ rises, O₂ is displaced from alveoli)
- Low inspired FiO₂ (altitude)
Diffusion
Gas exchange follows Fick's Law of Diffusion:
Volume of gas transferred ∝ (Area × ΔP × Diffusion coefficient) / Thickness
- CO₂ diffuses 20× faster than O₂ despite similar partial pressure gradients
- Therefore, diffusion impairment causes hypoxemia before hypercapnia
- DLCO (diffusing capacity for CO) is the clinical test - reduced in emphysema, ILD, pulmonary hypertension
7. Oxygen Transport
The Oxygen Cascade
PO₂ falls stepwise: Atmosphere (160 mmHg) → Trachea (149 mmHg) → Alveolus (~100 mmHg) → Arterial blood (~95 mmHg) → Tissue (~40 mmHg) → Mitochondria (~5 mmHg)
Oxygen Content of Blood (CaO₂)
CaO₂ = (Hb × 1.34 × SaO₂) + (0.003 × PaO₂)
- Hb-bound O₂ dominates (1.34 mL O₂/g Hb)
- Dissolved O₂ (0.003 × PaO₂) is minor under normal conditions but critical with hyperbaric O₂ therapy
Oxygen-Hemoglobin Dissociation Curve
The sigmoidal shape has major clinical implications:
| Segment | Clinical significance |
|---|
| Flat upper portion (PaO₂ >60 mmHg) | SaO₂ stays >90% even with significant drop in PaO₂ - protects against mild hypoxemia |
| Steep lower portion (PaO₂ <60 mmHg) | Small drop in PaO₂ causes large drop in SaO₂ - the "cliff" below which O₂ delivery crashes |
Bohr Effect - Rightward shift (↑ P50, ↓ O₂ affinity, ↑ O₂ unloading at tissues):
- ↑ Temperature, ↑ PCO₂, ↑ [H⁺] (acidosis), ↑ 2,3-DPG
- Physiologically appropriate during exercise (tissues get more O₂)
Leftward shift (↓ P50, ↑ O₂ affinity, ↓ tissue unloading):
- ↓ Temperature, ↓ PCO₂, alkalosis, ↓ 2,3-DPG, fetal Hb (HbF), CO poisoning, methemoglobinemia
Clinical point: Stored blood has low 2,3-DPG, shifting the curve left - massive transfusion patients may have impaired O₂ delivery to tissues despite adequate hemoglobin.
Causes of Hypoxemia - Summary Table
| Mechanism | PaO₂ | PaCO₂ | A-a gradient | Response to O₂ |
|---|
| Hypoventilation | ↓ | ↑ | Normal | Good |
| Low FiO₂ (altitude) | ↓ | ↓ | Normal | Good |
| V̇/Q̇ mismatch (low V̇/Q̇) | ↓ | Normal/↑ | ↑ | Partial |
| Shunt (V̇/Q̇ = 0) | ↓↓ | Normal | ↑ | Poor |
| Diffusion impairment | ↓ (exercise) | Normal | ↑ | Good |
8. Control of Breathing
Central Controllers
| Center | Location | Function |
|---|
| Pre-Bötzinger complex | Medulla | Primary rhythm generator (automatic breathing) |
| Dorsal respiratory group | Medulla | Inspiration timing |
| Ventral respiratory group | Medulla | Expiration and forced breathing |
| Pneumotaxic center | Upper pons | Limits inspiration, promotes rate |
| Apneustic center | Lower pons | Prolongs inspiration |
| Cortex | Parietal lobe | Voluntary breathing (speech, breath-holding) |
Chemoreceptors
Central chemoreceptors (medulla):
- Respond to CO₂/pH in CSF (CO₂ crosses BBB and forms H⁺ + HCO₃⁻)
- Primary driver of ventilatory drive under normal conditions
- Not directly sensitive to O₂
Peripheral chemoreceptors (carotid & aortic bodies):
- Respond to ↓ PaO₂ (primary), ↑ PaCO₂, ↑ [H⁺]
- Carotid bodies are the more important clinical ones (glossopharyngeal nerve, CN IX)
- Drive the hypoxic ventilatory response - activated when PaO₂ falls below ~60 mmHg
Critical clinical point: In COPD patients with chronic hypercapnia, central chemoreceptors become desensitized to CO₂. These patients rely on the hypoxic drive (peripheral chemoreceptors) to maintain ventilation. Giving high-flow O₂ without monitoring can blunt this drive and cause CO₂ narcosis. Target SpO₂ 88-92% in known hypercapnic COPD.
Mechanical Receptors
- Pulmonary stretch receptors (Hering-Breuer reflex): Activated by lung inflation; inhibit further inspiration - prevent over-inflation
- Irritant receptors: Respond to dust, smoke, noxious gases → cough, bronchoconstriction
- J-receptors (juxtacapillary): Stimulated by pulmonary congestion, edema → rapid shallow breathing and dyspnea in heart failure
9. Hypoxic Pulmonary Vasoconstriction (HPV)
A unique property of pulmonary vessels (opposite to systemic circulation):
- Low alveolar PO₂ → local vasoconstriction → diverts blood away from poorly ventilated areas → maintains V̇/Q̇ matching
- Mediators: inhibition of K⁺ channels, membrane depolarization, Ca²⁺ influx in pulmonary arterial smooth muscle
- HPV is inhibited by volatile anesthetic agents (clinically relevant during one-lung ventilation)
Clinical point: In chronic hypoxia (e.g., high altitude, COPD), generalized HPV → global pulmonary hypertension → right ventricular hypertrophy → cor pulmonale.
10. CO₂ Transport
CO₂ is transported in three forms:
| Form | % of Total | Notes |
|---|
| Bicarbonate (HCO₃⁻) | ~70% | CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻ (carbonic anhydrase in RBCs); HCO₃⁻ exits RBC in exchange for Cl⁻ (chloride shift) |
| Dissolved CO₂ | ~10% | PaCO₂ = 40 mmHg |
| Carbamino compounds | ~20% | CO₂ bound to Hb and plasma proteins |
Haldane Effect: Deoxygenated Hb binds CO₂ more efficiently than oxygenated Hb - explains why venous blood carries more CO₂ than arterial blood at the same PCO₂.
Clinical Summary: Putting It Together
| Physiological Concept | Clinical Condition | Key Mechanism |
|---|
| Low compliance | ARDS, fibrosis | High ventilating pressures needed; risk of barotrauma |
| Surfactant loss | NRDS, ARDS | Alveolar collapse, worsened by Laplace |
| Dead space ↑ | Pulmonary embolism | Wasted ventilation, ↑ PaCO₂, ↑ A-a gradient |
| Shunt | Consolidation, atelectasis | Hypoxemia refractory to O₂ |
| Low V̇/Q̇ | COPD, asthma | Partial O₂ response; chronic hypercapnia |
| HPV suppression | Volatile anesthetics | V̇/Q̇ mismatch during one-lung ventilation |
| Loss of hypoxic drive | High-flow O₂ in COPD | CO₂ retention, respiratory acidosis |
| FRC < closing capacity | Supine, obese, elderly | Dynamic airway collapse, shunt, hypoxemia |
Sources:
- Morgan & Mikhail's Clinical Anesthesiology, 7e - Ch. 23: Respiratory Physiology & Anesthesia, pp. 910-960
- Fischer's Mastery of Surgery, 8e - Normal Pulmonary Physiology, p. 264
- Costanzo Physiology, 7th Edition - V/Q Defects and Control of Breathing, pp. 234-240